Back to search

National and Kapodistrian University of Athens

Η επίδραση της θεραπείας καταστολής με θυροξίνη στην ογκομετρική οστική πυκνότητα και την οστική γεωμετρία σε γυναίκες με διαφοροποιημένο καρκίνο του θυρεοειδούς αδένα

Abstract

dc:description

Differentiated thyroid cancer (DTC) comprises the vast majority of all thyroid cancers (90%) and has an optimal prognosis that allows patients to live a long life with the condition of exogenous subclinical hyperthyroidism.After initial therapy, all the patients should be administered thyroid hormone in suppressive doses of thyroid stimulating hormone (TSH) inhibiting recurrence of disease. However, longitudinal TSH-suppression therapy has been associated with adverse effects on areal bone mineral density (aBMD) only in postmenopausal women. Dual X-ray absorptiometry (DXA) is currently the clinical gold standard technique for bone density assessment, but does not offer insight into compartment- specific bone densities.During the last 20 years peripheral quantitative computed tomography (pQCT) has emerged, which offers many opportunities for the investigation of bone mechanics. The purpose of the study was to examine the effect of TSH-suppression therapy on skeletal integrity using peripheral quantitative computed tomography (pQCT) at the radius and tibia in pre- and postmenopausal women with DTC and controls.Subjects included 80 women with DTC and 89 controls. pQCT was performed at the radius and tibia, DXA at the hip and lumbar spine, while samples were taken for calciotropic hormones and bone markers.No differences were observed concerning aBMD by DXA while pQCT results indicate that LT4 suppression therapy leads to significant trabecular bone loss only in postmenopausal women and mainly at non-weight bearing sites such as the radius. The lack of deficit at the respective distal site of the tibia probably indicates that mechanical loading protects, up to a point, against bone loss, a finding observed also in other high bone turnover disease states. The significant negative association between serum CTX and trabecular vBMD and BMC at both sites along with the preservation of the increased endocortical circumference at least at the radius, indicates that TSH suppression therapy probably leads to increased endocortical resorption and “trabecularization” of cortical bone along with significant reduction of cortical thickness. In premenopausal patients with DTC cortical thickness was higher in patients at the radius, a rather unexpected finding. Given that higher cortical thickness at the radius has been reported in patients with hypoparathyroidism, it is possible that higher cortical thickness is related to the “relative hypoparathyroidism” observed in this group following thyroidectomy.Given that differentiated thyroid cancer has become a chronic disease and that survivors are a growing population, assessment of affected skeletal sites and prevention of bone loss becomes critical in improving quality of life.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Antoniou, Julia
  • Αντωνίου, Ιουλία

Subjects

dc:subject × 14

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41910

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Antoniou, Julia; Αντωνίου, Ιουλία. Η επίδραση της θεραπείας καταστολής με θυροξίνη στην ογκομετρική οστική πυκνότητα και την οστική γεωμετρία σε γυναίκες με διαφοροποιημένο καρκίνο του θυρεοειδούς αδένα. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/41910